Category archives: Biomedicine

Plasticity in the macrophage activation states

Plasticity in the macrophage activation states

BiomedicineMolecular biology

By Invited Researcher

The immune system is composed of a considerable variety of cell types with different functions. One of the most important cells involved in the innate immunity are the macrophages . These cells have a wide spectrum of functions: from bacteria-killing function to wound healing properties. Classically the macrophages according to their functions have been classified […]

One year or one cell division older?

One year or one cell division older?

BiologyBiomedicineHealthMolecular biology

By Invited Researcher

Aging is one of those topics mankind is always trying to understand, especially whether it can be reversed or stopped. With increasing age come not only alterations in appearance, but also associated changes like the degeneration of tissues such as muscles, bone and neural tissues or a higher predisposition for disease. In recent years, we […]

Holidays, drug addiction…and cancer research

Holidays, drug addiction…and cancer research

BiochemistryBiomedicineMedicine

By Isabel Perez Castro

Cell signalling is the mechanism by which cells communicate with each other and with their environment. Stimuli, which are generally chemical, are transmitted via a signalling cascade to effector molecules that orchestrate the appropriate response. Signalling pathways are not isolated but they rather form a complex network of biochemical reactions that regulate processes such as […]

How drug discovery works: finding new strategies against Kaposi’s sarcoma

How drug discovery works: finding new strategies against Kaposi’s sarcoma

BiomedicineMedicinePharmacy

By Isabel Perez Castro

15% of human cancers worldwide may be attributed to viruses, 1 with both DNA and RNA viruses being capable of causing the disease. Epstein-Barr virus, human papilloma virus, hepatitis B virus, and human herpes virus-8 are the four DNA viruses capable of causing the development of human cancer, whereas human T lymphotrophic virus type 1 […]

Melodrama with happy ending for Duchenne Muscular Dystrophy patients

Melodrama with happy ending for Duchenne Muscular Dystrophy patients

BiologyBiomedicineGeneticsMedicinePharmacy

By Sergio Laínez

Patients suffering from rare diseases (defined by the European as those affecting less than 5 in 10000 people) have traditionally been overlooked by pharmaceutical companies. They are usually looking for the next blockbuster drug, so the lack of a large patient pool means they may not generate the revenue needed to justify the R&D financial […]

Sweet, sweet cancers

Sweet, sweet cancers

BiomedicineHealth

By Pasquale Pellegrini

So many times, I order my coffee while hesitantly eyeing the seductive pastries. This time I’ll resist these sweet beauties. Last night I came across a lecture from Einstein’s friend, Otto Heinrich Warburg (Nobel Prize in Medicine, 1931). It was 1966 and he was at the meeting of Nobel Laureates in Lindau, Germany: “ Cancer […]